RxDoctor Payments Data

Marian Dehlinger, MD

Psychiatry · Sumter, SCNPI 1720104565

Payments from drug & device makers

$1,366in general payments, 2019–2025

Across 72 payments — averaging $18.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$448
  • Neurocrine Biosciences, Inc.$225
  • Alkermes, Inc.$182
  • AbbVie$172
  • Teva Pharmaceuticals USA, Inc.$101
  • Otsuka America Pharmaceutical, Inc.$96
  • plus $143 from 5 others

What the payments were for

  • Food & beverage$1,366100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,366 in reported general payments places this provider in the 70th percentile of 624 psychiatry providers in South Carolina.

See all psychiatry providers in South Carolina

Medicare billing

Part B allowed, 2024
$34,172
Medicare patients
124
Services billed
422

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate12$101,064
Invega SustennaPaliperidone Palmitate14$34,693
Risperdal ConstaRisperidone Microspheres13$31,834
Lurasidone Hcl35$12,695
FetzimaLevomilnacipran Hcl24$11,110
Bupropion XlBupropion Hcl101$1,755
Quetiapine Fumarate127$1,329
Mirtazapine56$1,093
Trazodone Hcl167$906
Hydroxyzine Pamoate63$840
Venlafaxine Hcl ErVenlafaxine Hcl70$792
Benztropine Mesylate86$763
Hydroxyzine Hcl52$757
Divalproex Sodium ErDivalproex Sodium41$673
Buspirone Hcl62$671

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$225$101,06412 claims
Johnson & JohnsonInvega Sustenna, Risperdal Consta$448$66,52627 claims
AbbVieFetzima$172$11,11024 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 624 psychiatry providers in South Carolina.

Other psychiatry in Sumter

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →